Skip to main
University-wide Navigation

Journal announces UK's Donna Wilcock as new editor-in-chief

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

UK researcher leads study to advance treatment for hip osteoarthritis

Michael Samaan, Ph.D., is leading his own project funded by the National Institute of Aging, implementing a novel experimental approach to more effectively treat hip osteoarthritis.

BIRCWH program accepting applications for women's health research

The University of Kentucky's BIRCWH program supports young scholars in developing meaningful research careers in many areas of women's health.

$2.2 million NIH grant will allow UK team to optimize therapies for patients with heart failure

A team of cardiologists, scientists, and engineers at the University of Kentucky and beyond will create computer models to optimize therapy plans for patients with heart failure.

Honoring University Research Professor Peter Nelson

Peter T. Nelson, M.D., Ph.D., professor of pathology and laboratory medicine at the University of Kentucky College of Medicine and director of neuropathology at the Sanders-Brown Center on Aging, has been named one of 14 University Research Professors.

Undergrads Get Hands-on Summer Experience in Biomedical Research

Students in the Undergraduate Summer Training in Cardiovascular Research (USTiCR) program get hands-on lab training and experience and one-on-one mentorship from a UK faculty member.

UK Researchers Develop Antiviral Face Mask

A team of faculty and students have developed the face mask membrane that can capture and deactivate the SARS-CoV-2 spike protein on contact. The innovation is another layer of protection against COVID-19 that can help prevent the virus from spreading.

For UK Physician Mary Sheppard, Treating Rare Disease Is Personal

At age 5, Mary Sheppard, M.D., was diagnosed with Marfan syndrome, a rare connective tissue disorder affecting the heart, eyes, blood vessels and skeleton. Now a physician-scientist at UK, Sheppard studies and treats this rare disease and takes pride in giving back to the community.

UK’s HEALing Communities Study Begins WAVE 2 Intervention

Through the HEALing Communities Study intervention, communities in eight Kentucky counties will implement new recovery, treatment, and prevention strategies proven to reduce opioid overdose deaths.

New Drug Shows Promise Against Toxoplasmosis

Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis.